Zydus Lifesciences informs about press release

19 Dec 2024 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated December 19, 2024, titled ‘Zydus receives final approval from USFDA for Lidocaine and Prilocaine Cream USP, 2.5%/2.5%.’

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

973.90 -11.80 (-1.20%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.